Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHRM.L Regulatory News (PHRM)

  • There is currently no data for PHRM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Operational Update

8 Jul 2009 08:27

RNS Number : 3110V
Phorm Inc
08 July 2009
 



Phorm, Inc.

('Phorm' or the 'Company')

Operational update

Phorm (AIM: PHRM/PHRX), the personalisation technology company, makes the following clarificatory statement regarding its international progress and the UK market following recent press commentary.

International

Phorm has been focussing considerable effort on faster moving overseas opportunities to drive a first deployment of the Company's Webwise and Discover technology and to bring the Company to a revenue generating position. The Company continues to make excellent progress and is actively engaged in more than 15 markets worldwide including advanced negotiations with eight major ISPs of which three are engaged in trials.

Specifically, in Korea, live trials with KT, the leading Korean ISP remain on course with activities progressing in line with management expectations.

UK

In the UK, Phorm continues to hold a commercial agreement with BT. Following the trial of the Company's Webwise technology and the announcement of Phorm's consumer facing Webwise Discover product, BT plc ("BT") continues to believe that the interest-based advertising category offers major benefits for consumers and publishers alike. BT has confirmed to the Company that whilst it has no immediate plans to deploy and it is currently prioritising more pressing projects such as developing next generation broadband, it will monitor Phorm's progress with other internet service providers ("ISPs"). The Company is extremely encouraged by the fact that BT has stated that privacy was not a factor in their decision making. 

Virgin Media continues to believe interest-based advertising has potentially important benefits for consumers, ISPs and website owners. Given the fast moving nature of the sector, Virgin Media is extending its review of potential opportunities with suppliers including Phorm prior to making any commitment to launch any of these technologies

Unfortunately, on 7 July 2009, TalkTalk Telecom Ltd, a wholly owned subsidiary of the Carphone Warehouse Group PLC, terminated its agreement with Phorm. The Directors note that this relationship had not extended to any form of trial in contrast to BT and some international ISP's, as noted above.

Summary

Overall ISP discussions have been greatly accelerated by the launch of Webwise Discover and its clear benefit to consumers, which has been viewed as a key step forward by all of our partners, including those in the UK.  Phorm retains a strong balance sheet with adequate cash resources and the Directors remain very confident in Phorm's ability to deliver on the promise of this substantial opportunity.

  Enquiries: 

Phorm, Inc

Benjamin Usher

+44 20 7297 2521

Sarah Simon

+44 20 7297 2433

 

Citigate Dewe Rogerson

+44 20 7638 9571 

Justin Griffiths 

Simon Rigby

 

Canaccord Adams Limited

+44 20 7050 6500 

(Nominated Adviser)

Mark Williams

Andrew Chubb

About Phorm:

Phorm is a global personalisation technology company that makes content and advertising more relevant to the consumer. Phorm's innovative platform preserves user privacy and delivers a more interesting online experience.

Phorm's partners include leading Internet Service Providers (ISPs), Publishers, Ad Networks and Advertisers.

Phorm is a Delaware, US incorporated company, with offices in New York, Seoul, Moscow and London.

The Company was admitted to the AIM market of the London Stock Exchange in 2004 and has over 140 employees.

For more information, please visit: www.phorm.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCZGGGNNRKGLZG
Date   Source Headline
14th Apr 201610:00 amRNSUpdate and Resignation of Nominated Adviser
16th Mar 201612:37 pmRNSIssue of US$500,000 of Convertible Loan Notes
16th Mar 20167:00 amRNSIssue of US$500,000 of Convertible Loan Notes
25th Feb 20168:02 amRNSFunding Update and Statement re Suspension
25th Feb 20167:55 amRNSSuspension - Phorm Corporation Limited
4th Feb 20166:05 pmRNSFunding Update
1st Feb 20163:49 pmRNSSubscription Update, New Subscription & Loan
21st Jan 20167:00 amRNSPhorm Awarded TRUSTe Certified Privacy Seal
18th Jan 20167:00 amRNSSubscription & Operational Update
5th Jan 20162:00 pmRNSTR-1: Notification of major interest in shares
23rd Dec 20151:00 pmRNSRevised Non-Executive Director Compensation
22nd Dec 20157:00 amRNSDirectorate Change
7th Dec 20157:00 amRNSRepricing of Options
3rd Dec 201511:00 amRNSPhorm Enables Hover Rate with Insomnis Media
1st Dec 20157:00 amRNSNew Share Option Plan and Grant of Options
18th Nov 20157:00 amRNSTR-1: Notifications of Major Interests in Shares
28th Oct 20157:00 amRNSPartnering Agreement with INSOMNIS Media Limited
20th Oct 20157:00 amRNSAgreement with Causemo, Inc.
13th Oct 20157:00 amRNSPhorm Hires Chief Revenue Officer
9th Oct 20157:00 amRNSAgreement with Boston Globe Media Group
30th Sep 20151:33 pmRNSInterim Results
28th Aug 20152:38 pmRNSResult of AGM
10th Aug 20157:00 amRNSNotice of Annual General Meeting
7th Aug 20157:48 amRNSEquity fundraising of approximately £3.2 million
29th Jul 20157:02 amRNSUpdate re Board Changes
28th Jul 20157:00 amRNSLoan Agreement & Convertible Loan Note Extension
15th Jul 201511:21 amRNSBoard and Management Changes
3rd Jul 20157:00 amRNSOperational Update
2nd Jul 20157:16 amRNSDirectorate Change
30th Jun 20157:00 amRNSAnnual Financial Report
8th May 20154:00 pmRNSTR-1: Notification of major interest in shares
22nd Apr 20157:00 amRNSEquity Fundraising of £6.0 million Gross
21st Apr 20154:22 pmRNSOperational Update
16th Mar 20153:45 pmRNSDirectorate Change
25th Feb 20157:02 amRNSBoard Changes
19th Jan 20157:00 amRNSEquity fundraising of approximately £6.25 million
16th Jan 20157:21 amRNSOperational Update
8th Dec 20147:00 amRNSEquity Fundraising
28th Oct 20147:00 amRNSTR-1: Notification of major interest in shares
8th Oct 20147:00 amRNSEquity fundraising of £4.47 million
6th Oct 20147:00 amRNSOperational Update
22nd Aug 20147:05 amRNSSubscription To Raise £2.4 million
22nd Aug 20147:00 amRNSInterim Results
24th Jul 20142:31 pmRNSResult of Annual General Meeting
27th Jun 20147:30 amRNSGlobal Operations Update
27th Jun 20147:05 amRNSNotice of Annual General Meeting and Board Changes
27th Jun 20147:00 amRNSFinal Results for the Year Ended 31 December 2013
23rd Apr 20144:25 pmRNSTR-1: Notification of major interest in shares
14th Apr 201412:40 pmRNSResult of EGM
27th Mar 20147:00 amRNSProposed £10m Placing & Notice of EGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.